Beta-carotene in Multivitamins and the Possible Risk of Lung Cancer Among Smokers Versus Former Smokers : A Meta-analysis and Evaluation of National BrandsTANVETYANON, Tawee; BEPLER, Gerold.Cancer. 2008, Vol 113, Num 1, pp 150-157, issn 0008-543X, 8 p.Article

Screening for lung cancerPATZ, Edward F; GOODMAN, Philip C; BEPLER, Gerold et al.The New England journal of medicine. 2000, Vol 343, Num 22, pp 1627-1633, issn 0028-4793Article

RRM1-induced metastasis suppression through PTEN-regulated pathwaysGAUTAM, Ashish; LI, Zhan-Rong; BEPLER, Gerold et al.Oncogene (Basingstoke). 2003, Vol 22, Num 14, pp 2135-2142, issn 0950-9232, 8 p.Article

Integrating new targeted agents into the treatment of non-small-cell lung cancerTHATCHER, Nick.Lung cancer. 2006, Vol 54, issn 0169-5002, S25-S31, SUP2Article

Malignant pleural mesothelioma : A new standard of careSTAHEL, Rolf A.Lung cancer. 2006, Vol 54, issn 0169-5002, S9-S14, SUP2Article

Development of new first-line therapeutic options for non-small-cell lung cancerCRINO, Lucio; FOGLIETTA, Jennifer; HAMZAJ, Alketa et al.Lung cancer. 2006, Vol 54, issn 0169-5002, S19-S24, SUP2Article

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancerSIMON, George R; SHARMA, Swati; CANTOR, Alan et al.Chest. 2005, Vol 127, Num 3, pp 978-983, issn 0012-3692, 6 p.Article

Activated epidermal growth factor receptor-stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancerHAURA, Eric B; ZHONG ZHENG; LANXI SONG et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8288-8294, issn 1078-0432, 7 p.Article

Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung AdenocarcinomaANAGNOSTOU, Valsamo K; SYRIGOS, Konstantinos N; BEPLER, Gerold et al.Journal of clinical oncology. 2009, Vol 27, Num 2, pp 271-278, issn 0732-183X, 8 p.Article

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancerBEPLER, Gerold; KUSMARTSEVA, Irina; SHARMA, Swati et al.Journal of clinical oncology. 2006, Vol 24, Num 29, pp 4731-4737, issn 0732-183X, 7 p.Article

Expression of TGFβ type-II receptor in association with markers of proliferation and apoptosis in premalignant lung lesionsMUNOZ-ANTONIA, Teresita; MURO-CACHO, Carlos; SHARMA, Swati et al.Cancer. 2007, Vol 110, Num 7, pp 1527-1531, issn 0008-543X, 5 p.Article

Lung cancer chemoprevention : ACCP evidence-based clinical practice guidelines (2nd Edition)GRAY, Jhanelle; MAO, Jenny T; SZABO, Eva et al.Chest. 2007, Vol 132, Num 3, issn 0012-3692, 56S-68S, SUPArticle

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancerBEPLER, Gerold; SHARMA, Swati; CANTOR, Alan et al.Journal of clinical oncology. 2004, Vol 22, Num 10, pp 1878-1885, issn 0732-183X, 8 p.Article

Comparison of cytochrome P450 2A6 polymorphism frequencies in caucasians and African-Americans using a new one-step PCR-RFLP genotyping methodPASCHKE, Thilo; RIEFLER, Michelle; SCHULER-METZ, Annette et al.Toxicology (Amsterdam). 2001, Vol 168, Num 3, pp 259-268, issn 0300-483XArticle

Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patientsHARSHMAN, Lauren C; BEPLER, Gerold; ZHONG ZHENG et al.BJU international (Papier). 2010, Vol 106, Num 11, pp 1805-1811, issn 1464-4096, 7 p.Article

Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second-or Third-Line Therapy of Non-Small-Cell Lung CancerOH, Yun; HERBST, Roy S; BURRIS, Howard et al.Journal of clinical oncology. 2008, Vol 26, Num 7, pp 1135-1141, issn 0732-183X, 7 p.Article

Prognostic significance of gelsolin expression level and variability in non-small cell lung cancerJUN YANG; DONGFENG TAN; ASCH, Harold L et al.Lung cancer. 2004, Vol 46, Num 1, pp 29-42, issn 0169-5002, 14 p.Article

Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancerTAN, Dong-Feng; QIANG LI; RAMMATH, Nithya et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1665-1672, issn 0250-7005, 8 p.Article

Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quitMCBRIDE, Colleen M; HALABI, Susan; BEPLER, Gerold et al.Journal of health communication. 2000, Vol 5, Num 3, pp 229-241, issn 1081-0730Article

Choline Phosphate Cytidylyltransferase-α Is a Novel Antigen Detected by the Anti-ERCC1 Antibody 8F1 With Biomarker Value in Patients With Lung and Head and Neck Squamous Cell CarcinomasVAEZI, Alec E; BEPLER, Gerold; NIEDERNHOFER, Laura J et al.Cancer. 2014, Vol 120, Num 12, pp 1898-1907, issn 0008-543X, 10 p.Article

Randomized International Phase III Trial of ERCC1 and RRM1 Expression―Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non―Small-Cell Lung CancerBEPLER, Gerold; WILLIAMS, Charles; CHIAPPORI, Alberto et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2404-2412, issn 0732-183X, 9 p.Article

Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non-Small-Cell Lung CancerHAURA, Eric B; TANVETYANON, Tawee; LANXI SONG et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1387-1394, issn 0732-183X, 8 p.Article

Phase 2 Trial of Docetaxel and Gefitinib in the First-Line Treatment of Patients With Advanced Nonsmall-Cell Lung Cancer (NSCLC) Who Are 70 Years of Age or OlderSIMON, George R; EXTERMANN, Martine; BEPLER, Gerold et al.Cancer. 2008, Vol 112, Num 9, pp 2021-2029, issn 0008-543X, 9 p.Article

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancerANTONIA, Scott J; MIRZA, Noweeda; MENANDER, Kerstin et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 878-887, issn 1078-0432, 10 p., 1Article

Targeted therapy in combination with gemcitabine in non-small cell lung cancerROSELL, Rafael; CRINO, Lucio; SANCHEZ, Jose Javier et al.Seminars in oncology. 2003, Vol 30, Num 4, pp 19-25, issn 0093-7754, 7 p., SUP10Article